Antibody Evolution after SARS-CoV-2 mRNA Vaccination

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B-cell responses that continue to evolve for at least one year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern[1][1]. As a result, vaccination of coronavirus disease 2019 (COVID-19) convalescent individuals with currently…

Read the full article here

Related Articles